Abstract
Meniscal injury is a common problem among sportsmen and increasingly seen in the older and more active population. The traditional treatment options include a partial meniscectomy, which provides good mechanical and pain relief to the patient. However, the focus of treatment is shifting towards repairing meniscal tears where possible and replacement of the lost meniscal tissue where appropriate. Replacement can be total or partial. Total meniscal replacement using an allograft, is usually reserved for young patients, who meet certain criteria and who have undergone several subtotal meniscectomies or a single stage total meniscectomy and are still symptomatic. Partial meniscal replacement can be utilized in conjunction with a partial meniscectomy to fill the resulting space left by the resection. Collagen based implants and synthetic scaffolds have entered the European market but have demonstrated mixed results in clinical trials. Tissue engineering to create an implant that mimics the biomechanical properties holds much potential for future research.
Keywords: Meniscal replacement, meniscectomy, tissue engineering, meniscal substitute, biological material, meniscal injury.
Current Stem Cell Research & Therapy
Title:Clinical Studies Using Biological and Synthetic Materials for Meniscus Replacement
Volume: 12 Issue: 4
Author(s): David D Lin, Natasha E. Picardo*, Adetola Adesida and Wasim S Khan
Affiliation:
- Royal London Hospital, Whitechapel Road, London E1 1BB,United Kingdom
Keywords: Meniscal replacement, meniscectomy, tissue engineering, meniscal substitute, biological material, meniscal injury.
Abstract: Meniscal injury is a common problem among sportsmen and increasingly seen in the older and more active population. The traditional treatment options include a partial meniscectomy, which provides good mechanical and pain relief to the patient. However, the focus of treatment is shifting towards repairing meniscal tears where possible and replacement of the lost meniscal tissue where appropriate. Replacement can be total or partial. Total meniscal replacement using an allograft, is usually reserved for young patients, who meet certain criteria and who have undergone several subtotal meniscectomies or a single stage total meniscectomy and are still symptomatic. Partial meniscal replacement can be utilized in conjunction with a partial meniscectomy to fill the resulting space left by the resection. Collagen based implants and synthetic scaffolds have entered the European market but have demonstrated mixed results in clinical trials. Tissue engineering to create an implant that mimics the biomechanical properties holds much potential for future research.
Export Options
About this article
Cite this article as:
Lin D David, Picardo E. Natasha*, Adesida Adetola and Khan S Wasim, Clinical Studies Using Biological and Synthetic Materials for Meniscus Replacement, Current Stem Cell Research & Therapy 2017; 12 (4) . https://dx.doi.org/10.2174/1574888X11666160429123110
DOI https://dx.doi.org/10.2174/1574888X11666160429123110 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeted Therapies in Bone Sarcomas
Current Cancer Drug Targets Role of Neuronal Guidance Cues in the Pathophysiology of Obesity: A Peripheral and Central Overview
Current Pharmaceutical Design Targeting Microglial Activation in Stroke Therapy: Pharmacological Tools and Gender Effects
Current Medicinal Chemistry Editorial (Thematic Issue: Epilepsy and Its Therapy: Present and Future)
Current Medicinal Chemistry Chromatographic Retention Parameters in Medicinal Chemistry and Molecular Pharmacology
Current Medicinal Chemistry Lung Cancer May Increase Serum Procalcitonin Level
Infectious Disorders - Drug Targets Dermatologic Effects of Psychopharmacologic Agents in the Pediatric Population
Current Psychopharmacology Polyunsaturated Fatty Acids and Inflammation: Therapeutic Potential in Rheumatoid Arthritis
Current Rheumatology Reviews Mitigative Effects of a Combination of Multiple Pharmaceutical Drugs on the Survival of Mice Exposed to Lethal Ionizing Radiation
Current Pharmaceutical Biotechnology Genistein: A Phytoestrogen with Multifaceted Therapeutic Properties
Mini-Reviews in Medicinal Chemistry Genetics of Obesity: What have we Learned?
Current Genomics What is the Optimal Treatment for Anemia in Inflammatory Bowel Disease?
Current Drug Delivery Inflammation, High Density Lipoprotein and Endothelium
Current Medicinal Chemistry Patent Selections:
Current Biomarkers (Discontinued) The Role of Microbial Agents in the Etiology of Schizophrenia: An Infectious Hypothesis for Psychosis?
Current Immunology Reviews (Discontinued) Role of Immunostimulatory Molecules in Poultry Vaccines
Recent Patents on Biotechnology A Vector Based on the Chicken Hypersensitive Site 4 Insulator Element Replicates Episomally in Mammalian Cells
Current Gene Therapy Dietary Nutrients in Relation to Chronic Obstructive Pulmonary Disease: Emerging Epidemiological Evidence
Current Respiratory Medicine Reviews Biphasic Lipid Vesicles (Biphasix™) Enhance the Adjuvanticity of CpG Oligonucleotides Following Systemic and Mucosal Administration
Current Drug Delivery Coronary Risk Factors in the Elderly: Their Interactions and Treatment
Current Pharmaceutical Design